Brad J Biggerstaff Selected Research

Immunoglobulin M (IgM)

10/2021	Frequency of Zika Virus Immunoglobulin M Antibody in Persons with West Nile Virus Infection.
1/2021	The Specificity of the Persistent IgM Neutralizing Antibody Response in Zika Virus Infections among Individuals with Prior Dengue Virus Exposure.
12/2020	Evolving viral and serological stages of Zika virus RNA-positive blood donors and estimation of incidence of infection during the 2016 Puerto Rican Zika epidemic: an observational cohort study.
3/2019	Evaluation of in vivo expressed Borrelia burgdorferi antigens for improved IgM serodiagnosis of early Lyme disease.
1/2019	Evaluation of Patient IgM and IgG Reactivity Against Multiple Antigens for Improvement of Serodiagnostic Testing for Early Lyme Disease.
1/2018	Association and birth prevalence of microcephaly attributable to Zika virus infection among infants in Paraíba, Brazil, in 2015-16: a case-control study.
9/2016	Performance of Dengue Diagnostic Tests in a Single-Specimen Diagnostic Algorithm.
1/2014	Characteristics of antibody responses in West Nile virus-seropositive blood donors.
1/2013	Multiplex microsphere immunoassays for the detection of IgM and IgG to arboviral diseases.
11/2010	Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assays.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brad J Biggerstaff Research Topics

Disease

19	Infections 01/2022 - 05/2002
6	Japanese Encephalitis 01/2022 - 05/2002
5	Dengue (Dengue Fever) 01/2022 - 12/2003
4	Lyme Disease (Disease, Lyme) 01/2022 - 04/2003
3	Zika Virus Infection 10/2021 - 06/2009
3	Viremia 09/2016 - 08/2002
2	COVID-19 10/2022 - 01/2022
2	Reinfection 01/2022 - 12/2021
2	St. Louis Encephalitis 01/2022 - 09/2007
2	West Nile Fever 10/2021 - 06/2009
1	Yellow Fever 01/2022
1	red meat allergy 01/2021
1	Convalescence 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Microcephaly 01/2018
1	Vomiting 10/2014
1	Severe Dengue 10/2014
1	Shock 10/2014
1	Abdominal Pain (Pain, Abdominal) 10/2014
1	Vector Borne Diseases 01/2013
1	Encephalitis (Encephalitis, Rasmussen) 11/2010
1	Acute Febrile Encephalopathy 11/2010
1	Meningitis 11/2010
1	Transfusion Reaction 12/2007
1	Severe Acute Respiratory Syndrome 12/2007
1	Coinfection 12/2003
1	Asymptomatic Infections 08/2002
1	Virus Diseases (Viral Diseases) 05/2002
1	Infectious Encephalitis 05/2002

Drug/Important Bio-Agent (IBA)

15	Immunoglobulin M (IgM)IBA 10/2021 - 05/2002
10	AntibodiesIBA 10/2022 - 12/2003
7	VaccinesIBA 01/2022 - 04/2012
6	AntigensIBA 03/2019 - 05/2002
6	Immunoglobulin G (IgG)IBA 01/2019 - 04/2003
5	EnzymesIBA 09/2016 - 05/2002
5	ImmunosorbentsIBA 09/2016 - 05/2002
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2012
4	Neutralizing AntibodiesIBA 10/2021 - 12/2004
3	Indicators and Reagents (Reagents)IBA 01/2022 - 06/2006
3	RNA (Ribonucleic Acid)IBA 12/2020 - 12/2007
2	Viral AntigensIBA 02/2014 - 05/2002
1	Nucleic AcidsIBA 12/2021
1	Immunoglobulin E (IgE)IBA 01/2021
1	tert-butylserineIBA 01/2021
1	AcaricidesIBA 01/2021
1	Viral RNAIBA 12/2020
1	ORALIT (ORS)IBA 01/2018
1	SolutionsIBA 10/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2014
1	Colloids (Colloid)IBA 10/2014
1	ParaffinIBA 02/2014
1	paraform (paraformaldehyde)IBA 02/2014
1	N-acetyltalosaminuronic acid (NAT)IBA 06/2009
1	Solid WasteIBA 12/2003
1	PlasticsIBA 12/2003
1	Amino Acids FDA Link 04/2003
1	Immunoglobulins (Immunoglobulin)IBA 04/2003
1	Peptides (Polypeptides)IBA 04/2003

Therapy/Procedure

3	Microspheres (Microsphere) 10/2021 - 09/2007
3	Blood Transfusion (Blood Transfusions) 10/2014 - 08/2002
1	Home Nursing (Nursing, Home) 01/2022
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2014